Survival Analysis of Pathological T3a Upstaging in Clinical T1 Renal Cell Carcinoma

Aim: To evaluate the oncological outcomes of pathological T3a upstaging from clinical T1 renal cell carcinoma. Patients and Methods: We retrospectively studied patients who underwent radical or partial nephrectomy for clinical T1 renal tumors. Results: The median follow-up period was 44 months. At t...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:In Vivo
मुख्य लेखकों: LAI, GU-SHUN, LI, JIAN-RI, WANG, SHIAN-SHIANG, CHEN, CHUAN-SHU, YANG, CHUN-KUANG, HUNG, SHENG-CHUN, CHENG, CHEN-LI, OU, YEN-CHUAN, CHIU, KUN-YUAN
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: International Institute of Anticancer Research 2020
विषय:
Research Article
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC7157890/
https://ncbi.nlm.nih.gov/pubmed/32111787
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21873/invivo.11841
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन